Are you Dr. Cha?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
Box 1270 - M1286
San Francisco, CA 94143Phone+1 415-885-7276Fax+1 415-476-0624
Summary
- Dr. Edward Cha, MD is an oncologist in San Francisco, California. He is currently licensed to practice medicine in California and New York. He is affiliated with UCSF Medical Center and is a Clinical Fellow at UCSF School of Medicine.
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2008 - 2010
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2005 - 2008
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2005
Certifications & Licensure
- CA State Medical License 2008 - 2025
- NY State Medical License 2007 - 2009
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma Start of enrollment: 2012 Jun 09
Publications & Presentations
PubMed
- 14 citationsAtezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform.Andrew H Ko, Kyu-Pyo Kim, Jens T Siveke, Charles D Lopez, Jill Lacy
The Oncologist. 2023-06-02 - 4 citationsPhase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors.Christian U Blank, Deborah J Wong, Thai H Ho, Todd M Bauer, Carrie B Lee
Current Oncology. 2021-12-20 - 24 citationsEpigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.Raghav Sundar, Kie-Kyon Huang, Vikrant Kumar, Kalpana Ramnarayanan, Deniz Demircioğlu
Gut. 2021-08-25